A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Clinical trial NCT04024813 · TERMINATED

Trial details

NCT number: NCT04024813
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis

Start date: 2019-11-12
Primary completion: 2020-01-09
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.